These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 1740387)
1. America's pharmaceutical research companies: keeping the cost of health care down. Pharmaceutical Manufacturers Association. Hawaii Med J; 1992 Jan; 51(1):15-16, 19. PubMed ID: 1740387 [No Abstract] [Full Text] [Related]
2. Opinion: price controls on prescription drugs. Franks B N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791 [No Abstract] [Full Text] [Related]
3. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
4. Can price and regulatory controls replace free market competition in the drug industry? Buc NL; Levitt GM Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839 [No Abstract] [Full Text] [Related]
5. Health care reform and the pharmaceutical industry. Mossinghoff GJ Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353 [TBL] [Abstract][Full Text] [Related]
6. Exploring the rise in American pharmaceutical prices. Marwaha A Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(2):11-5. PubMed ID: 12099112 [No Abstract] [Full Text] [Related]
7. The demise of the blockbuster? Cutler DM N Engl J Med; 2007 Mar; 356(13):1292-3. PubMed ID: 17392299 [No Abstract] [Full Text] [Related]
8. Patent nonsense: evidence tells of an industry out of social control. Mintzberg H CMAJ; 2006 Aug; 175(4):374. PubMed ID: 16908900 [No Abstract] [Full Text] [Related]
9. The Canadians are killing us. Struble RA Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58-9. PubMed ID: 12592981 [No Abstract] [Full Text] [Related]
10. Prescription drug pricing: do competitive forces operate in the pharmaceutical marketplace? Margolis RE Healthspan; 1994 Feb; 11(2):9-16. PubMed ID: 10132991 [No Abstract] [Full Text] [Related]
11. Meeting resistance. Express Scripts-Medco deal called anti-competitive. Lee J Mod Healthc; 2011 Aug; 41(32):10-1. PubMed ID: 21879692 [No Abstract] [Full Text] [Related]
12. The pharmaceutical industry--prices and progress. Scherer FM N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432 [No Abstract] [Full Text] [Related]
13. Pricing pain: relief in sight on drug costs? J Am Health Policy; 1992; 2(6):28-31. PubMed ID: 10122415 [TBL] [Abstract][Full Text] [Related]
15. The pharmaceutical industry--to whom is it accountable? Holmer AF N Engl J Med; 2000 Nov; 343(19):1415; discussion 1417. PubMed ID: 11183877 [No Abstract] [Full Text] [Related]
16. Rx: Canadian drugs. Bugden S N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15014193 [No Abstract] [Full Text] [Related]
17. Will lower drug prices jeopardize drug research? A policy fact sheet. Light DW; Lexchin J Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915 [No Abstract] [Full Text] [Related]
18. Effect of generic drug competition on the price of prescription drugs in Ontario. Lexchin J CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888 [TBL] [Abstract][Full Text] [Related]
19. Redistribution of risk throughout the pharmaceutical industry. Scheur BS Med Interface; 1994 Oct; 7(10):77-80. PubMed ID: 10137569 [TBL] [Abstract][Full Text] [Related]
20. Two ideas to increase innovation and reduce pharmaceutical costs and prices. Jayadev A; Stiglitz J Health Aff (Millwood); 2009; 28(1):w165-8. PubMed ID: 19088104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]